Production (Stage)
Candel Therapeutics, Inc.
CADL
$5.03
-$0.13-2.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.58M | -55.18M | -52.20M | -49.99M | -37.37M |
| Total Depreciation and Amortization | 984.00K | 990.00K | 994.00K | 994.00K | 981.00K |
| Total Amortization of Deferred Charges | 231.00K | 270.00K | 304.00K | 325.00K | 331.00K |
| Total Other Non-Cash Items | 10.96M | 26.55M | 21.07M | 18.51M | 3.90M |
| Change in Net Operating Assets | 203.00K | 346.00K | 1.20M | -702.00K | 288.00K |
| Cash from Operations | -27.20M | -27.02M | -28.63M | -30.87M | -31.86M |
| Capital Expenditure | -12.00K | -16.00K | -60.00K | -163.00K | -326.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 20.00K | 20.00K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -16.00K | -40.00K | -143.00K | -306.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00M | -9.17M | -6.67M | -4.17M | -1.67M |
| Issuance of Common Stock | 103.67M | 103.45M | 9.03M | 4.86M | 412.00K |
| Repurchase of Common Stock | -- | -- | -121.00K | -121.00K | -121.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 93.67M | 94.28M | 2.25M | 569.00K | -1.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.45M | 67.24M | -26.43M | -30.44M | -33.55M |